Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Inscripta Snags $55.5 Million in Funding, Looks to Expand Employment February 27, 2018 Another Biotech Bites the Dust as Cambridge's Raze Shuts Down December 13, 2017 Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017
